Neal Flomenberg sold $1.7M of TVGN
See Remarks at Tevogen Bio Holdings Inc.. 1,078,600 shares at an average of $1.62, traded Oct 17, 2024, filed Oct 18, 2024.
Score components
- +15RoleOfficer
- +25Trade size$1.7M at market
- +5Share of holdings soldSold 20% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m -15.1%, 3m -25.6%, 6m -43.0%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001062993-24-017785, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Oct 17, 2024 | SOpen-market sale Common Stock | -1,078,600 | $1.62 | $1.7M | 4,254,302 | Oct 18, 2024 |
Related signals
Other insiders at Tevogen Bio Holdings Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 15Weak | TVGNsell Tevogen Bio Holdings Inc. | Neal Flomenberg See Remarks | $6,635 972 shares | -1% | |
| 50Moderate | TVGNsell Tevogen Bio Holdings Inc. | Ryan H. Saadi Chief Executive Officer | $1.8M 1,438,206 shares | -1% | |
| 28Weak | TVGNsell Tevogen Bio Holdings Inc. | Neal Flomenberg See Remarks | $254k 232,968 shares | -6% | |
| 28Weak | TVGNsell Tevogen Bio Holdings Inc. | Neal Flomenberg See Remarks | $232k 211,909 shares | -5% | |
| 28Weak | TVGNsell Tevogen Bio Holdings Inc. | Neal Flomenberg See Remarks | $250k 213,817 shares | -5% | |
| 33Weak | Tevogen Bio Holdings Inc. | Kirti Desai Chief Financial Officer | $2,460 3,000 shares | +0% | |
| 46Moderate | Tevogen Bio Holdings Inc. | Ryan H. Saadi Chief Executive Officer | $2,000 2,607 shares | +0% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.